Quick Takeaways
- Tasso Partners, LLC filed SCHEDULE 13G/A for PAVmed Inc. Common Stock, par value $0.001 per share (PAVM).
- Disclosed ownership: 15%.
- Date of event: 27 Mar 2026.
Tasso Partners, LLC - 27 Mar 2026 SCHEDULE 13G/A Report for PAVmed Inc. Common Stock, par value $0.001 per share (PAVM)
- Filing Manager
- Tasso Partners, LLC
- Reporting Manager
- Dana Carrera
- Symbol
- PAVM
- Shares outstanding
- 6,367,621 shares
- Disclosed Ownership
- 974,246 shares
- Ownership
- 15%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Apr 2026, 16:05:28 UTC
- Date of event
- 27 Mar 2026
- Previous filing
- 28 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Tasso Partners, LLC disclosed 15% ownership in PAVmed Inc. Common Stock, par value $0.001 per share (PAVM) on 27 Mar 2026."
What Changed
- Previous schedule filing date: 28 Feb 2025.
- Current filing was accepted on 14 Apr 2026, 16:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Tasso Partners, LLC | 14% | 912,996 | 0 | 912,996 | /s/ Dana Carrera | Dana Carrera/Manager of Tasso Capital, LLC, which controls Tasso Partners, LLC | |
| Dana Carrera | 15% | 974,246 | 61,250 | 912,996 | /s/ Dana Carrera | Dana Carrera |